Prenetics Global Ltd
PRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Other share classesPRENW
13F holders, Q3 2022
Institutional positions in Prenetics Global Ltd as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −1 vs. Q2 2022
- Shares held
- 5.71M
- −194.9K (−3.3%) vs. Q2 2022
- Total value
- $21.6M
- −$2.27M (−9.5%) vs. Q2 2022
- New holders
- 2
- 0 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $23.3M |
| Q1 2026 | 34 | $38.5M |
| Q4 2025 | 33 | $27.4M |
| Q3 2025 | 16 | $17.2M |
| Q2 2025 | 11 | $9.78M |
| Q1 2025 | 9 | $4.57M |
| Q4 2024 | 9 | $6.60M |
| Q3 2024 | 8 | $4.47M |
| Q2 2024 | 7 | $7.06M |
| Q1 2024 | 9 | $60.5M |
| Q4 2023 | 6 | $7.27M |
| Q3 2023 | 15 | $7.69M |
| Q2 2023 | 20 | $14.7M |
| Q1 2023 | 14 | $5.55M |
| Q4 2022 | 12 | $12.1M |
| Q3 2022 | 10 | $21.6M |
| Q2 2022 | 11 | $23.9M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Prenetics Global Ltd; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aspex Management (HK) Ltd | 5,192,250 | $19.6M | 0.58% | 00.0% | Unchanged |
| Millennium Management LLC | 226,181 | $855.0K | 0.00% | −124,711−35.5% | Reduced |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 217,107 | $821.0K | 1.12% | −27,761−11.3% | Reduced |
| Fan Yu | 25,000 | $95.0K | 1.29% | 00.0% | Unchanged |
| Vident Investment Advisory, LLC | 16,218 | $61.0K | 0.00% | +16,218 | New |
| Nine Masts Capital Ltd | 15,646 | $59.0K | 0.02% | −34,303−68.7% | Reduced |
| Oasis Management Co Ltd. | 11,732 | $44.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,856 | $22.0K | 0.00% | −6,434−52.4% | Reduced |
| Bank of America Corp | 1,654 | $6.00K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 226 | $0 | 0.00% | +226 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,740−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −4,736−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,704−100.0% | Sold out |